Company: TVRD
Filing Date: 2025-05-13
Form Type: 8-K/A
Source: 0001104659-25-047844
Chunk: 0

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-13
Form: 8-K/A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
April 15, 2025

TVARDI THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)</div>

| Delaware                                 |     | 001-36279   |     |         75-3175693 |
| (State or other jurisdiction             
 of incorporation)                        |     | -Commission 
 File Number |     |      -IRS Employer 
 Identification No. |
| 3 Sugar Creek Ctr. Blvd.                 
 Suite 525                                
 Sugar Land, Texas                        |     |             |     |              77478 |
| (Address of principal executive offices) |     |             |     |          -Zip Code |

<div align='center'>Registrant's telephone number, including area code: ( 713) 489-8654

N/A

(Former Name or Former Address, if Changed Since Last Report)</div>

Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction
A.2.):

| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |

| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |

| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |

| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of
the Act:

| Title of each class                      | Trading   
 Symbol(s) | Name of each exchange on which 
 registered                     |
| Common Stock, par value $0.001 per share | TVRD      | The Nasdaq Stock Market LLC    |

Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the